Methicillin-Resistant Staphylococcus Aureus: Difference between revisions
No edit summary |
No edit summary |
||
| Line 39: | Line 39: | ||
<br> | <br> | ||
add text here | add text here | ||
== Prevalence == | == Prevalence == | ||
<span> According to the 2012 US Census Data<ref name="MRSA">MRSA Tracking | MRSA | CDC [Internet]. Cdc.gov. 2016 [cited 7 April 2016]. Available from: http://www.cdc.gov/mrsa/tracking/index.html</ref></span> | <span> According to the 2012 US Census Data<ref name="MRSA">MRSA Tracking | MRSA | CDC [Internet]. Cdc.gov. 2016 [cited 7 April 2016]. Available from: http://www.cdc.gov/mrsa/tracking/index.html</ref></span> | ||
*Non-Dialysis Patients: 65,296<br> | *Non-Dialysis Patients: 65,296<br> | ||
| Line 63: | Line 63: | ||
*End-Stage Liver Disease | *End-Stage Liver Disease | ||
*Immunocompromised, Non-cancer<br> | *Immunocompromised, Non-cancer<br> | ||
*Solid-Organ Cancer | *Solid-Organ Cancer | ||
*Hematologic Malignancy<br> | *Hematologic Malignancy<br> | ||
| Line 88: | Line 88: | ||
*Joints | *Joints | ||
Please refer to the ‘Characteristics/Clinical Presentation’ section for more information on the associated signs and symptoms. | Please refer to the ‘Characteristics/Clinical Presentation’ section for more information on the associated signs and symptoms. | ||
== Medical Management (current best evidence) == | == Medical Management (current best evidence) == | ||
| Line 98: | Line 98: | ||
[[Image:Management of MRSA.jpg|left]]<br> | [[Image:Management of MRSA.jpg|left]]<br> | ||
<br> | |||
<br> | |||
<br> | |||
<br> | |||
<br> | |||
<br> | |||
<br> | |||
<br> | |||
<br> | |||
<br> | |||
<br> | |||
add text here | |||
add text here | |||
== Differential Diagnosis == | == Differential Diagnosis == | ||
| Line 130: | Line 130: | ||
add links to case studies here (case studies should be added on new pages using the [[Template:Case Study|case study template]])<br> | add links to case studies here (case studies should be added on new pages using the [[Template:Case Study|case study template]])<br> | ||
== Resources == | |||
== Resources | |||
add appropriate resources here | add appropriate resources here | ||
== Recent Related Research (from Pubmed) == | |||
<div class="researchbox"><rss>http://www.ncbi.nlm.nih.gov/entrez/eutils/erss.cgi?rss_guid=1T_hRitDi64RTP3G4MQAH0nGfcCJ5doV7EDFzffkl67UKYvsZ5|charset=UTF-8|short|max=10</rss><br></div> | |||
== References == | == References == | ||
Revision as of 03:44, 8 April 2016
Welcome to PT 635 Pathophysiology of Complex Patient Problems This is a wiki created by and for the students in the School of Physical Therapy at Bellarmine University in Louisville KY. Please do not edit unless you are involved in this project, but please come back in the near future to check out new information!!
Original Editors - Students from Bellarmine University's Pathophysiology of Complex Patient Problems project.
Top Contributors - Kory Reynolds, Sarah Tassinari, Lucinda hampton, Elaine Lonnemann, Kim Jackson, 127.0.0.1, Nupur Smit Shah, Evan Thomas and WikiSysop
Definition/Description[edit | edit source]
add text here
Prevalence[edit | edit source]
According to the 2012 US Census Data[1]
- Non-Dialysis Patients: 65,296
- Dialysis Patients: 14,041
- TOTAL 75,309
Characteristics/Clinical Presentation[edit | edit source]
add text here
Associated Co-morbidities[edit | edit source]
Characteristics of Patients at Time of Detection/Identification of MRSA[2][3]
- Heart Disease
- Asthma
- Diabetes Mellitus
- End-Stage Renal Disease
- End-Stage Liver Disease
- Immunocompromised, Non-cancer
- Solid-Organ Cancer
- Hematologic Malignancy
Medications[edit | edit source]
add text here
Diagnostic Tests/Lab Tests/Lab Values[edit | edit source]
add text here
Etiology/Causes[edit | edit source]
add text here
Systemic Involvement[edit | edit source]
MRSA Infection may affect but are not limited to:[4]
- Bloodstream
- Lungs
- Heart
- Bones
- Joints
Please refer to the ‘Characteristics/Clinical Presentation’ section for more information on the associated signs and symptoms.
Medical Management (current best evidence)[edit | edit source]
add text here
Physical Therapy Management (current best evidence)[edit | edit source]
add text here
Differential Diagnosis[edit | edit source]
add text here
Case Reports/ Case Studies[edit | edit source]
add links to case studies here (case studies should be added on new pages using the case study template)
Resources[edit | edit source]
add appropriate resources here
Recent Related Research (from Pubmed)[edit | edit source]
Failed to load RSS feed from http://www.ncbi.nlm.nih.gov/entrez/eutils/erss.cgi?rss_guid=1T_hRitDi64RTP3G4MQAH0nGfcCJ5doV7EDFzffkl67UKYvsZ5|charset=UTF-8|short|max=10: Error parsing XML for RSS
References[edit | edit source]
see adding references tutorial.
- ↑ MRSA Tracking | MRSA | CDC [Internet]. Cdc.gov. 2016 [cited 7 April 2016]. Available from: http://www.cdc.gov/mrsa/tracking/index.html
- ↑ Huang S, Hinrichsen V, Datta R, Spurchise L, Miroshnik I, Nelson K et al. Methicillin-Resistant Staphylococcus aureus Infection and Hospitalization in High-Risk Patients in the Year following Detection. PLoS ONE. 2011;6(9):e24340.
- ↑ Datta R, Huang S. Risk of Infection and Death due to Methicillin‐Resistant Staphylococcus aureus in Long‐Term Carriers. Clinical Infectious Diseases. 2008;47(2):176-181.
- ↑ Updated by: Jatin M. Vyas a. MRSA : MedlinePlus Medical Encyclopedia [Internet]. Nlm.nih.gov. 2016 [cited 7 April 2016]. Available from: https://www.nlm.nih.gov/medlineplus/ency/article/007261.htm
